MilliporeSigma
  • SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.

SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.

Oncotarget (2017-02-02)
Guiqin Song, Kang Liu, Xiaolin Yang, Bo Mu, Junbao Yang, Lang He, Xin Hu, Qiujiang Li, Yunxia Zhao, Xiaoming Cai, Gang Feng
ABSTRACT

Esophageal cancer is a highly aggressive malignancy with very poor overall prognosis. Given the strong clinical relevance of SATB1 in esophagus cancer and other cancers suggested by previous studies, the exact function of SATB1 in esophagus cancer development is still unknown. Here we showed that the knockdown of SATB1 in esophageal cancer cell lines diminished the cell proliferation, survival and invasion. Whole genome transcriptome analysis of SATB1 knockdown cells revealed the different gene expression profiles between TE-1 cells and MDA-MB-231 cells. Network analysis and functional experiments further identified FN1 and PDGFRB to be key downstream genes regulated by SATB1 in esophageal cancer cells. Importantly, FN1 and PDGFRB were found to be highly expressed in human esophageal cancer. In summary, we provided the first molecular evidence that SATB1 played an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-FN1 antibody produced in rabbit, affinity isolated antibody